Peter Paul Foderick, MD | |
506 4th Ave W, 506 Fourth Ave.w, Ada, MN 56510-1011 | |
(218) 784-4848 | |
Not Available |
Full Name | Peter Paul Foderick |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 506 4th Ave W, Ada, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336315043 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 13953 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Peter Paul Foderick, MD 506 Fourth Ave.w, P.o.box189, Ada, MN 56510-0189 Ph: (218) 784-4848 | Peter Paul Foderick, MD 506 4th Ave W, 506 Fourth Ave.w, Ada, MN 56510-1011 Ph: (218) 784-4848 |
News Archive
But officials say the closings, which planned to shutter six of the city's 12 mental health clinics, actually expanded care for those with mental illnesses.
An estimated 7 million people will shop for individual health coverage this fall in the new online health insurance marketplaces, with another 2 million seeking coverage through the law's small business program. Federal and state officials are working full tilt to have them ready in time.
Caris Life Sciences, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced the results of a study identifying the clinical benefit of targeted therapy in colorectal cancer (CRC) with high microsatellite instability (MSI-H), a predisposition that occurs in 15% of all CRCs causing significantly different prognosis and response to treatment.
OracleBio, providers of high precision digital image analysis services for detailed quantification of histological marker staining within cells and tissues, is pleased to announce it will be a principal sponsor of the forthcoming Tumor Models conference to be held in Boston, MA on the 23-25th July.
Specific combinations of gut bacteria produce substances that affect myelin content and cause social avoidance behaviors in mice, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published today in the medical journal eLife. This research suggests that targeting intestinal bacteria, or their metabolites, could be one way to treat debilitating psychiatric disorders and demyelinating diseases, like multiple sclerosis.
› Verified 3 days ago